echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Azurity launches Katerzia oral fluid in U.S. market

    Azurity launches Katerzia oral fluid in U.S. market

    • Last Update: 2020-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, Azurity Pharmaceuticalscompany(http:// announcedthe introduction of Katerzia (amlodipine, amchloride) oral suspension (1mg/mL) in the U.SmarketKaterzia oral fluid spout is suitable for the treatment of hypertension in children and adults aged 6 and over, and the treatment of coronary artery disease in adultsAbout KaterziaKaterzia was approved in July by the u.SFDA(http://, a ready-to-use (simple shake) oral suspension that will provide a safe, effective, and simpleproduct(http://for children 6 years and older who need or prefer oral aminechlorohydroIn June, Cutis Pharma, theof bio
    pharmaceutical http:// announced the acquisition of Silvergate Pharmaceuticals and will merge with it to form its new company, Azurity Pharmaceuticals   It is understood that the combined Azurity Pharmaceuticals is a privately held professional pharmaceutical company   Azurity Pharmaceuticals' business focus is primarily on meeting the needs of a wide range of patients, especially children and the elderly   Azurity Pharmaceuticals current products include Epaned (Malay acid iraply) oral solution, Qbrelis (Reinopli) oral solution, Xatmep (methotrexate) oral solution, FIRVANQ (vancomycin hydrochloric acid) oral solution, and FIRST composite (http:// kit
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.